Neurofeedback From the Supplementary Motor Area for Tourette Syndrome

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable

This is a clinical trial where adolescents aged 10-16 years old with Tourette Syndrome (or chronic tic disorder) are randomized to receive either real-time functional magnetic resonance imaging (fMRI) neurofeedback targeting the supplementary motor area (for the experimental intervention) or real-time fMRI neurofeedback (NF) from a control region (for the control intervention).

Participation Requirements
Sex: All
Minimum Age: 10
Maximum Age: 16
Healthy Volunteers: No

• Boys and girls, 10 to 16 years of age

• A current diagnosis of Tourette Syndrome (TS) or chronic tic disorder, with active tics that can be executed without head movement, and a YGTSS score of at least 13

• Currently stable medication treatment and no planned changes in medication for the duration of the study.

• Family residence within 2 hours of Yale Medical Center with ability and willingness to attend assessment and fMRI visits.

• Children and their parents are expected to be able to speak and understand spoken English in order to participate in a clinical assessment of TS and related psychopathology.

• Subjects will be free of: 1) metal medical implants or braces, 2) pregnancy, and will have 3) a body weight of less than 250 lbs. and 4) no claustrophobia.

United States
Yale University School of Medicine
New Haven
Contact Information
Cheyenne Harris-Starling
Jitendra Awasti
Time Frame
Start Date: November 1, 2022
Estimated Completion Date: January 20, 2027
Target number of participants: 64
Experimental: Neurofeedback from the SMA
Active Comparator: Neurofeedback from control region
Michelle Hampson
Leads: Yale University
Collaborators: National Institute of Mental Health (NIMH)

This content was sourced from

Similar Clinical Trials